Doxycycline in either capsules or tablets will be administered at 400mg total per day. Patients will be treated for five months, or up to one year for those with a partial response at 5 months. Doxycycline for the Treatment of Cutaneous T-Cell Lymphoma (CTCL)
| Official Title: | Doxycycline in Patients With Relapsed Cutaneous T-cell Lymphoma |
| Actual Study Start Date : | February 6, 2018 |
